Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.

Not Applicable

Completed

• Conditions: Drug Use; Quality of Life

• Registration Number: NCT03393299
• Lead Sponsor: Lille Catholic University

Brief Summary

Assess the impact of the systematic use of STOPP/START tool during medication conciliation on the evolution of hospitalised elderly people's quality of life at 2 months.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-01-02
• Study First Submitted QC: 2018-01-02
• Study First Posted: 2018-01-08
• Study Start: 2018-01-16
• Primary Completion: 2018-07-17
• Study Completion: 2018-10-30
• Status Verified: 2020-08
• Last Update Submitted: 2020-08-04
• Last Update Posted: 2020-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

• Patient with more than 75 years old
• Hospitalized in geriatrics short-stay
• Patient with a written informed consent
• Patient with a social security scheme

Exclusion Criteria

• Severe dementia
• Not able to respond to SF-12
• Disease at final stage
• Patient under legal protection (maintenance of justice, tutelage, legal guardianship)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
SF-12 Quality of life scale	at inclusion and at 2 months	The evolution of the hospitalised elderly people's quality of life at 2 months will be measured by the SF-12 scale.

Secondary Outcome Measures

Name	Time	Method
Number of falls	at 2 months	The number of falls during the two months following the inclusion will be collected for each patient.
Proportion of patients rehospitalized	at 2 months	The proportion of patients that have been rehospitalized (unscheduled hospitalization) during the two months following inclusion will be measured.
Mortality	at 2 months	The mortality during the two months following inclusion will be measured.

Trial Locations

Locations (1)

Hôpital La Porte Verte; 🇫🇷 Versailles, France